Panagora Asset Management Inc Abbott Laboratories Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Panagora Asset Management Inc holds 211,801 shares of ABT stock, worth $23.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

211,801

Previous 30,085 604.01%

Holding current value

$23.9 Million

Previous $3.13 Million 672.46%

% of portfolio

0.12%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $18.2 Million - $21.5 Million	181,716 Added 604.01%	211,801 $24.1 Million
Q2 2024 Jul 29, 2024	BUY	$100.73 - $112.44 $213,950 - $238,822	2,124 Added 7.6%	30,085 $3.13 Million
Q1 2024 May 07, 2024	BUY	$109.52 - $120.96 $126,714 - $139,950	1,157 Added 4.32%	27,961 $3.18 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $65,297 - $79,929	724 Added 2.78%	26,804 $2.95 Million
Q3 2023 Oct 31, 2023	BUY	$95.53 - $114.62 $44,994 - $53,986	471 Added 1.84%	26,080 $2.53 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $77.1 Million - $85.9 Million	-765,061 Reduced 96.76%	25,609 $2.79 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $2.95 Million - $3.47 Million	-30,408 Reduced 3.7%	790,670 $80.1 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $47,054 - $55,202	495 Added 0.06%	821,078 $90.2 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.86 Million - $2.16 Million	19,258 Added 2.4%	820,583 $79.4 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $14.3 Million - $17.3 Million	-140,529 Reduced 14.92%	801,325 $87.1 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $30.3 Million - $37 Million	265,758 Added 39.31%	941,854 $111 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $12.9 Million - $15.8 Million	111,810 Added 19.81%	676,096 $95.2 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $17.2 Million - $19.1 Million	147,816 Added 35.49%	564,286 $66.7 Million
Q2 2021 Aug 11, 2021	BUY	$105.79 - $124.53 $982,154 - $1.16 Million	9,284 Added 2.28%	416,470 $48.3 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $5.39 Million - $6.35 Million	-49,515 Reduced 10.84%	407,186 $48.8 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $26.9 Million - $29.4 Million	-256,621 Reduced 35.98%	456,701 $50 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $21.4 Million - $26 Million	233,362 Added 48.62%	713,322 $77.6 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $16.1 Million - $20.6 Million	-210,708 Reduced 30.51%	479,960 $43.9 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $58 Million - $84.9 Million	-924,020 Reduced 57.23%	690,668 $54.5 Million
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $32.9 Million - $36.6 Million	-418,866 Reduced 20.6%	1,614,688 $140 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $24.1 Million - $26.2 Million	294,745 Added 16.95%	2,033,554 $170 Million
Q2 2019 Aug 09, 2019	BUY	$72.88 - $85.0 $10.4 Million - $12.1 Million	142,211 Added 8.91%	1,738,809 $146 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $57.1 Million - $69 Million	-862,153 Reduced 35.06%	1,596,598 $128 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $68.6 Million - $77.7 Million	1,045,696 Added 74.0%	2,458,751 $178 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $80.5 Million - $97.1 Million	1,323,908 Added 1485.08%	1,413,055 $104 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $56,879 - $62,777	-988 Reduced 1.1%	89,147 $5.44 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $934,194 - $1.06 Million	16,602 Added 22.58%	90,135 $5.4 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $935,159 - $1 Million	17,421 Added 31.05%	73,533 $4.2 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $2.7 Million - $3.01 Million	56,112	56,112 $2.99 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Abbott Laboratories Transaction History